NASDAQ:RDHL RedHill Biopharma (RDHL) Stock Price, News & Analysis $10.93 +2.19 (+25.06%) (As of 08/21/2024 ET) Add Compare Share Share Today's Range$7.97▼$11.2450-Day Range$0.32▼$475.0052-Week Range$6.43▼$82.00Volume359,983 shsAverage Volume21.07 million shsMarket Capitalization$348.34 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Get RedHill Biopharma alerts: Email Address Ad Angel PublishingWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment for as much as $7,882 — each quarter.Discover how to receive your FIRST "Stimulus Stipends" payment for up to $7,882 here. About RedHill Biopharma Stock (NASDAQ:RDHL)RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H. pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its pipeline consists of five therapeutic candidates, which are in clinical development include opaganib for treating patients hospitalized with SARS-CoV-2 severe COVID-19 pneumonia, advanced unresectable cholangiocarcinoma, prostate cancer, and nuclear radiation protection; RHB-107 (upamostat) for treating outpatients infected with SARS-CoV-2 (COVID-19 disease) and advanced unresectable cholangiocarcinoma; RHB-104 for Crohn's disease; RHB-102 (Bekinda) for the treatment of acute gastroenteritis and gastritis, irritable bowel syndrome with diarrhea, and oncology support anti-emetic; and RHB-204 for pulmonary nontuberculous mycobacteria infections caused by mycobacterium avium complex. The company was incorporated in 2009 and is headquartered in Tel Aviv, Israel.Read More RDHL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RDHL Stock News HeadlinesAugust 21 at 7:00 AM | prnewswire.comTalicia® Launched in the United Arab EmiratesAugust 19 at 3:52 PM | msn.comIsrael-Based RedHill's Investigational COVID-19 Treatment Shows Encouraging Action In Obesity And DiabetesAugust 22, 2024 | Behind the Markets (Ad)Secure this "AI Fuel" Stock Before the Billionaires Buy It AllAccording to the Washington Post, America is running out of a crucial component for AI. Without this "AI fuel," firms like NVIDIA would have to shut down their operations.August 19 at 7:00 AM | prnewswire.comRedHill Announces Positive Obesity and Diabetes Results with OpaganibAugust 18, 2024 | americanbankingnews.comRedHill Biopharma (NASDAQ:RDHL) Now Covered by StockNews.comAugust 17, 2024 | finanznachrichten.deRedHill Biopharma Ltd.: RedHill Biopharma Announces Plan to Implement ADS Ratio ChangeAugust 16, 2024 | prnewswire.comRedHill Biopharma Announces Plan to Implement ADS Ratio ChangeAugust 1, 2024 | investorplace.comWhy Is RedHill Biopharma (RDHL) Stock Up 75% Today?August 22, 2024 | Behind the Markets (Ad)Secure this "AI Fuel" Stock Before the Billionaires Buy It AllAccording to the Washington Post, America is running out of a crucial component for AI. Without this "AI fuel," firms like NVIDIA would have to shut down their operations.August 1, 2024 | prnewswire.comNewly Published Positive Phase 3 Data Demonstrates 64% Increased Efficacy with RedHill's RHB-104 in Crohn's DiseaseJuly 25, 2024 | bizjournals.comRaleigh pharma gets cash jolt at critical timeJuly 22, 2024 | prnewswire.comRedHill Biopharma Strengthens Cash Balance, Settles Obligations and Removes Talicia® LienJuly 9, 2024 | prnewswire.comRedHill Biopharma Terminates License Agreement for Aemcolo®June 3, 2024 | prnewswire.comRedHill Announces a New Patent Covering Opaganib in Combination with Immune Checkpoint Inhibitors, Valid Through 2040May 22, 2024 | uk.finance.yahoo.comPensioners win £9,000 back in 16-year council tax battleMay 7, 2024 | finanznachrichten.deRedHill Biopharma Ltd.: RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035May 6, 2024 | prnewswire.comRedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035April 24, 2024 | finance.yahoo.comRedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 StudySee More Headlines Receive RDHL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RedHill Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/30/2021Today8/21/2024Next Earnings (Estimated)8/22/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:RDHL CUSIPN/A CIK1553846 Webwww.redhillbio.com Phone972-3541-3131Fax972-3541-3144Employees210Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio0.84 Quick Ratio0.61 Sales & Book Value Annual Sales$6.53 million Price / Sales49.72 Cash Flow$37.69 per share Price / Cash Flow0.29 Book Value$0.11 per share Price / Book99.36Miscellaneous Outstanding Shares29,703,000Free Float27,680,000Market Cap$324.65 million OptionableNo Data Beta3.64 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Dror Ben-Asher (Age 58)Co-Founder, Chairman & CEO Comp: $594.61kMr. Razi Ingber (Age 40)Chief Financial Officer Comp: $339.82kMr. Gilead Raday MPhil (Age 49)MSc, Chief Operating Officer Comp: $365.56kMr. Adi Frish (Age 54)Chief Corporate & Business Development Officer Comp: $339.3kMr. Rick D. Scruggs (Age 64)Chief Commercial Officer, President of RedHill Biopharma Inc. & Director Comp: $469.8kMs. Alexandra OkmianSenior Business Development & Investor Relations ManagerDr. Reza Fathi Ph.D. (Age 69)Senior Vice President of Research & Development Comp: $299.29kMr. Guy Goldberg J.D. (Age 48)Chief Business Officer Comp: $338.13kDr. June S. Almenoff FACP (Age 67)M.D., Ph.D., Chief Medical Officer Ms. Patricia Anderson B.Sc. RACSenior Vice President of Regulatory AffairsMore ExecutivesKey CompetitorsSelecta BiosciencesNASDAQ:SELBConcert PharmaceuticalsNASDAQ:CNCECytomX TherapeuticsNASDAQ:CTMXBeyondSpringNASDAQ:BYSIMagenta TherapeuticsNASDAQ:MGTAView All Competitors RDHL Stock Analysis - Frequently Asked Questions How have RDHL shares performed this year? RedHill Biopharma's stock was trading at $912.50 on January 1st, 2024. Since then, RDHL stock has decreased by 98.8% and is now trading at $10.93. View the best growth stocks for 2024 here. How were RedHill Biopharma's earnings last quarter? RedHill Biopharma Ltd. (NASDAQ:RDHL) announced its quarterly earnings results on Tuesday, November, 30th. The biotechnology company reported ($500.00) earnings per share (EPS) for the quarter, missing the consensus estimate of ($480.00) by $20.00. The biotechnology company earned $21.61 million during the quarter, compared to analyst estimates of $23.41 million. When did RedHill Biopharma's stock split? RedHill Biopharma's stock reverse split on the morning of Tuesday, August 20th 2024. The 1-25 reverse split was announced on Friday, August 16th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 19th 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. How do I buy shares of RedHill Biopharma? Shares of RDHL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of RedHill Biopharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that RedHill Biopharma investors own include Agenus (AGEN), Sorrento Therapeutics (SRNE), Sangamo Therapeutics (SGMO), Verastem (VSTM), Amarin (AMRN), Aralez Pharmaceuticals (ARLZ) and Inovio Pharmaceuticals (INO). This page (NASDAQ:RDHL) was last updated on 8/22/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredAir Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could becom...DTI | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredAmazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored625,000% GainThe recent crypto pullback has been brutal, causing widespread panic among investors. But for us, it’s just an...Crypto Swap Profits | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredThe #1 A.I. Crypto You Don’t Own (YET!)Markets are volatile right now—stocks, cryptos, you name it. But here's a crucial fact everyone is missing:...Crypto 101 Media | SponsoredYou’ve been lied to for 615 days, and countingAll of the hype around artificial intelligence has been nothing but an artificial illusion…Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RedHill Biopharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share RedHill Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
